Good morning :)
Add to Watchlist
Share

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund

Growth
41.640.05% (+0.02)

How to use scorecard? Learn more

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund

Growth
EquitySectoral Fund - Pharma & Health Care
Large-size FundAssets Under Mgmt: ₹ 5,044 Cr
Very High RiskPrinciple investment will be at very high risk
41.640.05% (+0.02)

Price Chart

High
—
Low
—
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

How to use scorecard? Learn more

EquitySectoral Fund - Pharma & Health Care
Large-size FundAssets Under Mgmt: ₹ 5,044 Cr
Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
1.0945.262.97
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.4752.722.16

Scheme Info

PlanPlanLock inLock inExit LoadExit Load
Growth0 yrs1.00%
1% on or before 15D Nil after 15D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care

Returns

Scheme

Ratios

Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund47.55%25.81%24.74%
Nippon India Pharma Fund35.26%20.71%19.15%
SBI Healthcare Opp Fund43.11%24.84%19.03%
DSP Healthcare Fund41.17%22.99%27.93%

Price Comparison

Compare ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund with any MF, ETF, stock or index
Compare ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund with any MF, ETF, stock or index
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Asset Allocation

Actual

Target

Mar 2024

Jun 2024

Sep 2024

Nov 2024

ACTUAL
Cash & EquivalentsEquity2.73%97.27%

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Distribution

+1 moreMiscellaneousInsuranceOthersLabs & Life Sciences ServicesPharmaceuticals1.12 %1.68 %2.40 %5.74 %13.30 %75.75 %

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Weightage

Sep 23Dec 23Mar 24Jun 24Sep 24Nov 2471.33%71.22%71.58%72.54%71.68%75.75%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change
  • Sun Pharmaceutical Industries Ltd
    SUNPHARMA
    3M change : -1.39 %

    Holdings

    13.77 %

    -1.39 %
  • Dr Reddy's Laboratories Ltd
    DRREDDY
    3M change : 1.83 %

    Holdings

    8.48 %

    1.83 %
  • Cipla Ltd
    CIPLA
    3M change : 1.17 %

    Holdings

    7.94 %

    1.17 %

AMC Profile

ICICI Prudential Asset Management Company Ltd. is the leading AMC in the leading AMC in the country. The AMC is joint venture between ICICI Bank and Prudential Plc, one of the UK's largest players in the financial services sectors.

  • No.of Schemes

    99

  • Total AUM

    ₹ 8,23,247.59 Cr.

Fund Manager Profile

Dharmesh Kakkad

AUM:  ₹93,959.88 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: —

Qualification

Data not available

Past Experience

Data not available

Funds Managed (20)

Manager Performance (0)

Loading...

Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Opinions and Fund Reviews

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
Hmm, looks like data is unavailable here. Please come back after some time.